Cargando…
Human Absorbed Dose Estimation of (111)In-DOTA-PR81 as a Novel High Potential Agent for Breast Cancer Imaging
PURPOSE: In this study, the human absorbed dose of (111)In-DOTA-PR81 as a new radioimmunoconjugate for single-photon emission computed tomography (SPECT) imaging of MUC1 + breast cancer was determined. MATERIALS AND METHODS: The complex was prepared at optimized conditions in about 1 h and 38°C. The...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542994/ https://www.ncbi.nlm.nih.gov/pubmed/36212201 http://dx.doi.org/10.4103/jmp.jmp_72_21 |